OptimizeRx Corporation (OPRX)

OptimizeRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	13.85	18.21	84.68	10.52	18.85
Short-Term Investments	0	55.93	0	0	0
Cash & Cash Equivalents	13.85	74.14	84.68	10.52	18.85
Cash Growth	-81.32%	-12.45%	705.21%	-44.22%	111.49%
Receivables	36.25	22.16	24.8	17.89	7.42
Other Current Assets	4.23	2.28	5.63	4.46	0.87
Total Current Assets	54.33	98.58	115.11	32.86	27.14
Property, Plant & Equipment	0.72	0.37	0.47	0.59	0.74
Goodwill and Intangibles	127.75	35.7	25.39	26.86	28.68
Other Long-Term Assets	0.57	0.01	0.01	0.01	0.08
Total Long-Term Assets	129.04	36.07	25.87	27.47	29.5
Total Assets	183.37	134.65	140.99	60.33	56.64
Accounts Payable	2.23	1.55	0.61	0.62	0.49
Deferred Revenue	0.17	0.16	1.39	0.29	0.58
Current Debt	2.22	0.09	0.09	0.12	0.12
Other Current Liabilities	13.26	6.59	7.28	9	4.92
Total Current Liabilities	17.88	8.4	9.37	10.03	6.11
Long-Term Debt	34.6	0.14	0.24	0.33	0.45
Other Long-Term Liabilities	4.34	0	0	0	5.22
Total Long-Term Liabilities	38.94	0.14	0.24	0.33	5.67
Total Liabilities	56.82	8.54	9.61	10.35	11.78
Total Debt	36.82	0.23	0.33	0.45	0.56
Debt Growth	15607.62%	-28.46%	-26.97%	-20.46%	-
Retained Earnings	-64.26	-46.69	-35.25	-35.63	-33.42
Shareholders' Equity	126.55	126.11	131.38	49.97	44.86
Net Cash / Debt	-22.97	73.91	84.35	10.07	18.29
Net Cash / Debt Growth	-	-12.39%	737.84%	-44.95%	105.17%
Net Cash Per Share	-1.34	4.16	4.77	0.68	1.37
Working Capital	36.45	90.18	105.74	22.83	21.03
Book Value Per Share	7.39	7.09	7.63	3.37	3.35

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).